Share on StockTwits

Perrigo Company PLC (NASDAQ:PRGO) EVP John T. Hendrickson sold 2,533 shares of Perrigo Company PLC stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $148.44, for a total value of $375,998.52. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

PRGO has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Monday, August 18th. They now have a $156.00 price target on the stock. Separately, analysts at B. Riley upgraded shares of Perrigo Company PLC from a “neutral” rating to a “buy” rating in a research note on Friday, August 15th. They now have a $180.00 price target on the stock, up previously from $157.00. Finally, analysts at Jefferies Group raised their price target on shares of Perrigo Company PLC from $160.00 to $176.00 in a research note on Friday, August 15th. They now have a “buy” rating on the stock. Three analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $166.92.

Perrigo Company PLC (NASDAQ:PRGO) traded up 0.09% during mid-day trading on Tuesday, hitting $148.12. 560,404 shares of the company’s stock traded hands. Perrigo Company PLC has a 52 week low of $115.94 and a 52 week high of $168.39. The stock has a 50-day moving average of $149.7 and a 200-day moving average of $148.. The company has a market cap of $19.821 billion and a P/E ratio of 83.61.

Perrigo Company PLC (NASDAQ:PRGO) last released its earnings data on Thursday, August 14th. The company reported $1.74 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.55 by $0.19. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. On average, analysts predict that Perrigo Company PLC will post $7.39 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 16th. Shareholders of record on Friday, August 29th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, August 27th.

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Receive News & Ratings for Perrigo Company PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.